June 26, 2019 by Independent.ie - Irish RSS Feed AbbVie to buy Allergan in $63bn deal Drug company AbbVie is to buy Botox-maker Allergan for around $63bn (€55bn), grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira. From our friends over at the : Independent.ie - Irish RSS Feed You can see the Full Story: Click Here